Evidence map›Paper›PMID 34309031›Full record

ArticleVox sanguinis2022

Impacts of COVID-19 and elective surgery cancellations on platelet supply and utilization in the Canadian Province of British Columbia.

Kevin E Shopsowitz, Christina Lim, Andrew W Shih, Nick Fishbane, Brian R Berry, Mark Bigham, Tanya Petraszko, Jacqueline Trudeau, Maureen Wyatt, Matthew T S Yan and 1 more

Abstract read
In one paragraph

Article in Vox sanguinis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kevin E ShopsowitzDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.ORCID https://orcid.org/0000-0003-3988-0837
Christina LimBC Provincial Blood Coordinating Office, Vancouver, British Columbia, Canada.
Andrew W ShihDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Nick FishbaneBC Provincial Blood Coordinating Office, Vancouver, British Columbia, Canada.
Brian R BerryDepartment of Pathology, Vancouver Island Health Authority, Victoria, British Columbia, Canada.
Mark BighamCanadian Blood Services, Vancouver, British Columbia, Canada.
Tanya PetraszkoCanadian Blood Services, Vancouver, British Columbia, Canada.
Jacqueline TrudeauDepartment of Anesthesia, Pharmacology, and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
Maureen WyattDepartment of Pathology and Laboratory Medicine, Interior Health Authority, Kelowna, British Columbia, Canada.
Matthew T S YanDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Douglas MorrisonDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Funding

None
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe coronavirus disease 2019 (COVID-19) pandemic raised concerns about the vulnerability of platelet supply and the uncertain impact of the resumption of elective surgery on utilization. We report the impact of COVID-19 on platelet supply and utilization across a large, integrated healthcare system in the Canadian province of British Columbia (BC). MATERIALS AND

methodsHistorical platelet use in BC by indication was compiled for fiscal year 2010/2011-2019/2020. Platelet collections, initial daily inventory and disposition data were assessed pre-COVID-19 (1 April 2018-15 March 2020) and for two COVID-19 time periods in BC: a shutdown phase with elective surgeries halted (16 March-17 May, 2020) and a renewal phase when elective surgeries resumed (18 May-27 September 2020); comparisons were made provincially and for individual health authorities.

resultsHistorically, elective surgeries accounted for 10% of platelets transfused in BC. Initial daily supplier inventory increased from baseline during both COVID-19 periods (93/90 units vs. 75 units pre-COVID-19). During the shutdown phase, platelet utilization decreased 10.4% (41 units/week; p < 0.0001), and remained significantly decreased during the ensuing renewal period. Decreased platelet utilization was attributed to fewer transfusions during the shutdown phase followed by a decreased discard/expiry rate during the renewal phase compared to pre-COVID-19 (15.2% vs. 18.9% pre-COVID-19; p < 0.0001). Differences in COVID-19 platelet utilization patterns were noted between health authorities.

conclusionDecreased platelet utilization was observed in BC compared to pre-COVID-19, likely due to a transient reduction in elective surgery as well as practice and policy changes triggered by pandemic concerns.

Indexed as

COVID-19Blood PlateletsBritish ColumbiaElective Surgical ProceduresHumansSARS-CoV-2platelet transfusiontransfusion medicinetransfusion strategy

Identifiers

PMID34309031
PMCPMC8447158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.